EIF3S2 Antibody (N-term) Blocking Peptide

Background:
EIF3S2 is the largest of the EIFs. It consists of at least 10 nonidentical subunits in mammals. In S. cerevisiae the p39 subunit contains WD repeats; these are thought to mediate protein-protein interactions. The p39 protein appears to be essential for maintaining the integrity of the yeast EIF3 complex. The mammalian EIF3-p36 subunit is homologous to yeast p39.

Other Names:
Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008}, eIF3i {ECO:0000255|HAMAP-Rule:MF_03008}, Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008}, TGF-beta receptor-interacting protein 1, TRIP-1, eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008}, eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008}, EIF3I {ECO:0000255|HAMAP-Rule:MF_03008}

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8547a was selected from the N-term region of human EIF3S2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: EIF3I {ECO:0000255|HAMAP-Rule:MF_03008}

Gene ID: 8668
Primary Accession: Q13347
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.